Trial · NCT03887169
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Tolerance Assessment | From day 0 to day 75 | No adverse event from day 0 to day 75. |
| Secondary | Respiratory rate (cycles /min) | At day 0, day 15, day 30, day 45, day 60, day 75 | number of cycles per minute |
| Secondary | Oxygen need (L/min) | At day 0, day 15, day 30, day 45, day 60, day 75 | Flow in L/min |
| Secondary | Respiratory signs of struggle | At day 0, day 15, day 30, day 45, day 60, day 75 | Presence or absence of signs |
| Secondary | Lung lesions | At Day 60 | Lesions appearance on thoracic CT scan, scored form 0 to 4 |
| Secondary | Lipo-proteinaceous material | At each bronchial-alveolar washes during the 2,5 months | Fluid examination |
| Secondary | Weight | At Day 15, Day 30, Day 45, Day 60, Day 75 | To evaluate Nutritional status |
| Secondary | mid upper arm circumference / head circumference rapport | At Day 15, Day 30, Day 45, Day 60, Day 75 | To evaluate Nutritional status |
| Secondary | Hepatomegaly | At Day 0, Day 15, Day 30, Day 45, Day 60, Day 75 | liver damage evaluate by physician during clinical examination |
| Secondary | cholestasis and hepatic cytolysis | At Day 0, Day 15, Day 30, Day 60, Day 75 | liver damage evaluate by biological parameters : ASAT, ALAT, GGT, PAL, Bilirubin |
| Secondary | Hepatomegaly | At Day 0 and Day 60 | liver damage evaluate by echography |
| Secondary | C reactive protein | At Day 0, Day 30, Day 60 | Biological parameters to evaluate Systemic inflammation |
| Secondary | sedimentation rate | At Day 0, Day 30, Day 60 | Biological parameters to evaluate Systemic inflammation |
| Secondary | Immunoglobulin G level | At Day 0, Day 30, Day 60 | Biological parameters to evaluate Systemic inflammation |
| Secondary | Haemoglobin level | At Day 0, Day 30, Day 60 | Biological parameters to evaluate inflammatory anaemia |
| Secondary | Plasma concentration of methionine | From Day 0 to Day 75 | Variation of the concentration for each patient |
| Secondary | Plasma concentration of homocysteine | From Day 0 to Day 75 | Variation of the concentration for each patient |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03887169/registered